Podcast appearances and mentions of cornell center

Do you feel like you can't afford your horse? You're not alone. Understand how to manage horse expenses to lessen the stress of horse keeping. The cost of horse ownership varies from region to region, but even basic expenses such as feed, bedding, and routine veterinary and farrier care can be very costly. Emergency veterinary expenses can soar depending on the illness or injury. Preparing for routine expenses and potential emergencies by budgeting can help horse owners obtain financial security for costs associated with horse ownership. In this episode of Ask TheHorse Live, two experts join us to answer common questions about budgeting and planning for horse expenses.This podcast is brought to you by CareCredit. About the Experts: Jorge L. Colón, DVM, MBA, is an associate professor of practice in financial and organizational management at the Cornell University College of Veterinary Medicine (CVM), in Ithaca, New York, and serves as the director of business education for the Cornell Center for Veterinary Business and Entrepreneurship. He received his BS and DVM from Cornell and his MBA from the College of Business at Colorado State University, in Fort Collins. Colón spent the first 25 years of his professional veterinary career as an equine ambulatory veterinarian in Lexington, Kentucky, concentrating in the areas of equine reproduction, neonatology, radiology, and Thoroughbred sales. He transitioned into academia in 2020, where he is now tasked with the development and implementation of the veterinary business educational curriculum at the Cornell CVM and with the management and administration of the Cornell CVBE Certificate in Veterinary Business and Management.Wendy Krebs, DVM, is a partner at Bend Equine Medical Center in Bend, Oregon. She grew up in Western Oregon, where she participated first in 4-H and later in eventing. She graduated from Oregon State University College of Veterinary Medicine, in Corvallis, in 2002 and performed a yearlong equine internship, followed by a four-year American College of Veterinary Surgeons equine surgery residency. Her practice interests include surgery and performance horse care, as well as comprehensive preventive care. She lives on a small working ranch in Tumalo with her husband, two young children, and a bevy of animals, including nine horses. She enjoys riding her Oldenburg mare, Aria, emergency-schedule permitting.

In this month's Discussions with DPIC, Managing Director Anne Holsinger speaks with Sandra Babcock (pictured), Clinical Professor at Cornell Law School, Faculty Director, and founder of the Cornell Center on the Death Penalty Worldwide. Ms. Babcock's clinic currently represents death sentenced women in the United States, Malawi, and Tanzania and is focused on providing defense teams in retentionist countries with training and consultation in order to provide the best possible legal representation for individuals facing sentences of death. The Cornell Center on the Death Penalty Worldwide also produces research highlighting the intersection of gender and the death penalty, as well as international legal issues and capital punishment. Ms. Babcock explains how the Center's research has uncovered widespread, yet overlooked issues that women and other gender minorities face in the criminal legal system.

Shannon Westin speaks with Holly Prigerson and Alfred Neugut about their thought-provoking editorial, "You Get (Offered) What You (Can) Pay For: Explaining Disparities in End-of-Life Cancer Care." TRANSCRIPT The guest on this podcast episode has no disclosures to declare.   Dr. Shannon Westin: Hello, everyone, and welcome to another episode of the JCO After Hours podcast. And this is where we get in-depth on manuscripts and editorials that have been published in the Journal of Clinical Oncology. As always, I am your host, Shannon Westin, Gynecologic Oncologist and Social Media Editor for the Journal of Clinical Oncology, and I'm so excited to be here today. We are going to be talking about a very compelling editorial that is called “You Get (offered) What You (can) Pay for: Explaining Disparities in End-of-Life Cancer Care." And this was published on June 20th, 2023, in the Journal of Clinical Oncology as an editorial on an article entitled the "End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting." So a very timely topic and very exciting for us to discuss today. I'm joined by two of the authors of the editorial, Dr. Holly Prigerson, Professor of Sociology and Medicine, the Irving Sherwood Wright Professor in Geriatrics Medicine at the Weill Cornell Medical College and the Director of Cornell Center for Research on End-of-Life Care. Welcome, Dr. Prigerson. Dr. Holly Prigerson: Great to be here. Dr. Shannon Westin: And also accompanied by Dr. Alfred Neugut, the Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University and the former Associate Director for Population Science and Racial Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia. Welcome, Dr. Neugut. Dr. Alfred Neugut: Thank you very much. Dr. Shannon Westin: Very excited to talk about this topic today, and I like to always start with a little bit of level setting. So I'd love for one of you to discuss: How common is the use of systemic anticancer treatment at the end of life? Dr. Holly Prigerson: So, based on the article, it looks like the rates within the last 30 days of death, it was 34% on average overall. So that was sort of the—you say level setting—the base statistic. Within 14 days of death, it dropped to 13% overall. So all the associations that are described are really disparities from that level.  Dr. Neugut: Speaking as an oncologist, I don't think any of my clinical colleagues will be surprised that it's that high. There is an effort made really to, in desperation, try to help. Patients want it. Families want it. So there really is efforts made to try to do that to prolong life or palliate or whatever. Dr. Holly Prigerson: The design also, which is probably going to be a question that's coming up, does raise a question for me that I'm wondering if Al could enlighten at least me on. They did select patients who were getting treatment for metastatic or advanced cancer starting in 2011 and then who died four years later. Does the selection for the fact that they were getting treatment initially—because everyone, that's how they sampled the study—does that increase the likelihood that they'll get treatment later on so that the rates are somewhat inflated is my question.   Dr. Alfred Neugut: Yeah, no, for sure. People who start chemo tend to continue partially because there is a certain amount of those who do well do well. If you respond to chemo initially, you tend to respond to the second-line therapy, you tend to respond to third-line therapy. If you didn't do well on first-line chemo, you're not likely to respond to a second line or a third line, so you don't have the enthusiasm to continue with it, and the patient certainly tends to lose interest in it. So you're right; there is a certain, call it, momentum or inertia in going forward with chemo once you've started. Dr. Shannon Westin: I mean, I think this just always highlights some of the issues we have, right, with any kind of retrospective data is how well can we design a population without—because we can't always do randomized control trials, and certainly not in this kind of setting. That would not be acceptable, I think, to providers nor patients. And I do agree that it can be tricky. Any other kind of, maybe just to help the listeners if they haven't gotten a chance to read this Canavan study, about the design, exactly what they were looking at in this population?   Dr. Holly Prigerson: Basically, they took these patients who were getting systemic therapy and had advanced metastatic cancer prior, and then who died. So there's always a question about the sampling on death issue, that they had to have died to be in the sample. So those are methodological issues, but there's really very little way around that. If you want to know what treatments people received in the last month of life, they have to die for there to be a last month of life.  So then the treatments were divided into chemotherapy alone, chemotherapy with immunotherapy, and then immunotherapy with and without targeted therapy. So there were three types of treatment, which is sort of an important update because Al and I had published something in 2015 on chemotherapy and the outcome of what was called palliative chemotherapy at that time. And this was sort of a very refreshing–well, not—I shouldn't say refreshing, but important update to our study, which had said that there are questionable outcomes of palliating someone with palliative chemotherapy so far along in the disease. And then the question became, well, is it different? Is it different with immunotherapies? Is it different with targeted therapies? And that's why I was delighted to see this paper, because it answered…  Dr. Alfred Neugut: I'd have to say there are probably differing views on this, but Holly and I are probably relatively nihilistic in terms of thinking that chemotherapy in late stages or near terminal patients is probably not all that helpful. Third-line, fourth-line therapy probably not going to get you very far. And maybe it's best to be thinking more about hospice care and supportive care. And now we have terrific palliative care programs at most or all cancer centers, and we really should be taking advantage of this. I think a real benchmark study was the Temel study from 2010 or 2011, which really—for those of your listeners who haven't read it or seen it, they should really take a look at it. It really changes the playing field and makes you realize that treatment is not really always the best thing for patients, and there are other options. And we go to hospice care or palliative care really, I think, too late in the game a lot of the time, and we really should be thinking otherwise.  Dr. Holly Prigerson: That is one of the outcomes that we had looked at before. So we had looked at palliative chemo, and not only does it not palliate, and we didn't show that it significantly enhanced survival; we also showed that it resulted in a lower likelihood of earlier enrollment in hospice, a higher likelihood of not dying where your family members thought you would have wanted to die, a higher likelihood of dying in the ICU or getting some kind of aggressive care. So it's not only what the chemo does or doesn't do in terms of treatment or survival or quality of life; it also seems to exacerbate and put someone at risk for very burdensome interventions that having avoided it might have enabled patients to avoid getting very burdensome care that's largely futile. But as Al said, we are probably more the nihilistic type.  Dr. Shannon Westin: Well, I think you bring up a couple of good points because you've got objective data, and these studies that you're mentioning are just some of them that show that early hospice care and early enrollment and even just a palliative care program or a supportive care program or whatever terminology we want to use, people do better, right? They live longer actually from that piece rather than necessarily the more “aggressive measures” of chemotherapy and things. Dr. Holly Prigerson: When there was an extra analysis of the Temel data, I believe they had shown that some of the survival advantage was explained by avoiding toxic chemo. So that's directly relevant. Dr. Alfred Neugut: There is an on the other hand, as always, which is that patients and families often don't want to do that. I mean, they realize that doing that is giving up, so they're reluctant to take hospice care or palliative care as an alternative to another cycle of chemo or another type of chemo. And as you say, you never know; maybe the next one is going to be the winner and there'll be a miracle or there'll be at least some substantial benefit. And then there's always experimental therapy, and now immunotherapy, which is the topic of this article, is the new winner on the block. And it has bright lights around it, and everybody has great hope for it. And it's the new kid on the block, and everyone hopes that that's going to be the big savior.  Dr. Shannon Westin: Right, and I think everyone knows of a story of somebody that was “on death's door” and got immunotherapy or the newest targeted therapy or the newest ADC, so that definitely colors it. And that also colors, I think, the physicians that are offering it, right? Because, yes, I've definitely heard this, and I'm sure you guys have too: nobody should die with such and such cancer without receiving immunotherapy once or without receiving such and such targeted therapy. I hear people say this all the time, and I don't necessarily disagree. It's more that when are we giving it, right? So we should be thoughtful about when we're placing those things. But you're right; there's so many factors that go into these decisions, and it's not cut and dry around what the patients and the family members and the physicians are going to decide. Dr. Holly Prigerson: And I think that Al hits on a really key issue when he used the word “hope” because that seems like what the negotiation appears to be all about. You don't want to disparage someone or not offer them hope if there might… No one wants to say that there isn't hope. No one wants to be the bearer of that kind of bad news. And I guess it leads to—I think that that's part of the driver that ends up providing the gas that drives people to getting more aggressive therapies is because no one wants to be the person to be the wet blanket and disparage hope. And so it might affect how treatments are sold to patients or at least communicated to patients.   There was this one finding in this report that was curious, and it was that patients with undocumented performance status were the ECOG group most likely to get treatment. And so, in terms of what could be done going forward to make people more realistic and not offer hope where it's really, really unlikely, maybe employing more decision rules about requiring the documentation of performance status and ensuring that it's what the ASCO guidelines permit for administering another line of treatment. Because that might be a way to sort of use data to help correct what in psychology we call cognitive distortion, so correct the distortion of this hyper-optimism. It might help correct some of that. We don't want to overcorrect and make people hopeless or depressed, but we want to offer realistic options.  I think that's part of why this paper is so important, and it sort of informs future research to try to unpack some of the findings that they didn't have data on physician characteristics or communication discussions between patients and their oncologists. And maybe that's where the money is. Maybe that's where offering hope in a realistic way or different forms of hope, what to hope for, might be better communicated through more effective communication strategies and ways to enhance patients' abilities to understand what they're agreeing to or not agreeing to.  Dr. Alfred Neugut: And I would add that it's easy for us to sit here and be dispassionate or scientific interlocutors and saying, you know, “It doesn't work, and therefore we're not going to offer it or you shouldn't get it or go on to hospice.” But it's different when you're on the other side of the table. And even us doctors or healthcare professionals or scientists, when you're sitting on the other side of the table and you're the one who's got the cancer or your mother or child, you're not going to be so easily dismissive of getting third-line chemotherapy and having your 5% chance that the tumor will respond to some cocktail of who knows what and you never know. I don't want to say anybody's wrong or that it's stupid. Everybody has to do what they have to do, and we at least have to think about it and know what we're doing and have realistic—at least some idea of the realism of what we're putting people through and the costs and the toxicities and what to expect. Dr. Shannon Westin: I think you guys brought up some really great points, and I do think that there is a huge impact around the communication piece. And we actually just did a podcast on discussion of goals of care at the end of life for adolescents and young adults and how those conversations can be different.  I think the other thing that really caught my eye and, of course, caught your eye when you did the editorial around the Canavan study was this idea that the patients with insurance—with all other things being equal, that the patients with insurance were more likely to receive end-of-life systemic treatment. And it's interesting because typically I feel like we think having insurance and having that support is always a positive thing and has a positive impact on our health, and it most certainly does. So that's not up for grabs. But then this particular study showed that it could potentially have been negative because of all the things that you all just said about the negative impact of care in this 30 days or even 14 days near the end of life. What are the opportunities for intervention at the insurance level? You talked a little bit about provider level and communication. Are there opportunities at the insurance level that we could address? Dr. Holly Prigerson: It does seem like having insurance companies determine what is reasonable and not reasonable to reimburse for. So including things, I would think, like having performance status factored in. What are the criteria for determining whether it's high value care or not? And I'm not an oncologist, so I really am going out on a limb, and I really want Al to respond to that question. But from my perspective, it seems like the ASCO guidelines determine when it's—“low-value care” is how they put. It's wasteful and futile and burdensome. And they have guidelines of performance status, having not responded to multiple lines of chemotherapy, so that there could be guidelines for when there is value and when there isn't and that it could be more values driven in terms of guidelines of what they would reimburse. Because, as our title implicated, it seems like you get offered what insurance companies are willing to pay for, and that leads to potential disparities in equity if you have different insurance than other people and fairness and justice. Those seem like valid questions to raise. Dr. Alfred Neugut: I mean, I think if we're following randomized trials and evidence-based medicine, then I think we're in a reasonable area of what should be done and could be done and needs to be done. And almost always, insurance will follow those. You don't usually end up then having to argue with a peer-to-peer call to the insurance company under those circumstances. Where things get sticky is when you want to treat someone off-label or go off the reservation. I don't know if that's to some degree what this paper talked about. And there you probably don't get much benefit from treatment if it's not a data-driven use of the drug. So that's really, I think, where the line needs to be drawn. I don't think there you'll have an insurance problem if you've stated those sorts of guidelines. If you want to use NCCN or the ASCO guidelines, all good and reasonable. The problem is when someone's desperate and you're trying to make them happy, so you give them something even though there's no reason on God's earth why it should work, but just so they feel like you're getting something and you're not being abandoned, which sometimes you do feel pressured to do that, and very commonly you do. And maybe that's where racial disparities save the uninsured from being tortured for something that's not likely to really be very helpful.  Dr. Holly Prigerson: But as someone who's a disparities researcher as well, it raises the question were Black patients—which these data couldn't answer: were they offered different treatments than the White patients? And I think we all agree that low-value treatments shouldn't be offered or received, but the fact that Black patients receive less of the expensive stuff, the newer cutting edge, is problematic. And I think there does need to be more research into equity in terms of the options presented to patients with similar diagnoses. That was the troubling aspect of it, not that they weren't getting, in essence, better end-of-life cancer care, but that's beside the point. In terms of ethics, it would be nice to have known whether they were offered the same things and declined it. I think all of us are a little suspicious that maybe they weren't.  Dr. Shannon Westin: Yeah, that definitely—I like how you said it. It struck a nerve. Like, when I was reading through both the article and your editorial, that was something that caught my eye is this evidence of how implicit bias is impacting what people are offered. And yes, it ended up being an overall benefit to underrepresented minority patients. However, that wasn't necessarily the intention or why that happened. So I would be interested to hear what you all think about what we know about how implicit bias impacts the care of patients with cancer, just for our listeners, and specifically what particular treatments are offered, not necessarily just at the end of life, but just across the cancer continuum.  Dr. Alfred Neugut: There are estimates—if you read the medical literature on health policy and things like that, there are estimates that we overdo a lot of things in medicine and give—I don't know. I've read that like 70% of what we do in medicine is unnecessary. I'm not saying in oncology necessarily, but screening and wellness care, etc. And so oncology probably is equally guilty of such things. And there are biases in that as well, so, you know, that's what happens.   Dr. Holly Prigerson: And in the article, they had cited, I think it's Penner. There was a study that showed that ratings of an oncologist's implicit bias were negatively associated with Black patients' willingness to undergo their treatment recommendations. So the dynamic between what's offered, what's heard, what's trusted. There's obvious history of Tuskegee and concerns about being denied treatment. So this article kind of feeds into why was the latest and greatest types of treatment not as common? That said, the actual differences, if you look in the tables, the actual differences weren't that disparate. They were statistically significant, but we're talking like 37% to 34%. So the disparity isn't as wide as to cause serious alarm bells to go off that people are being treated so differently. But it does raise a lot of underlying concerns that you would want to make sure that everyone's being offered the same things. So it does imply—that Penner article implied—it's basically medical mistrust may be interfering with a Black patient's willingness to undergo or accept some treatment offered. So if you follow the logic on that through, then the intervention would be: What are ways to enhance medical mistrust of their oncologist? What are the reasons for it? And how can patients feel that they are being treated by someone who treats them fairly and no differently than White patients? And so efforts in those directions seem like they might pay off in terms of enhancing and addressing implicit bias.  Dr. Shannon Westin: Well, this has been a really great discussion. I'd love to hear just kind of your last thoughts from each of you around some of the unmet needs. We've heard themes throughout the discussion, but maybe just sum it up for the podcast listeners, bring them back and where we need to go next here.  Dr. Holly Prigerson: Al and I have been working on a few different projects to address medical mistrust and leveraging things like healthcare chaplains, who might be liaisons within an outpatient oncology setting. We also have interventions that try to enhance clinical communication, like what we call a GIST, so that patients easily get the gist, the essential meaning of things like scan results to sort of level the playing field so that patients have adequate information to know what the harms and benefits of the treatments that they're being offered might be and have a better background to be engaged in those decisions in the first place.  Dr. Alfred Neugut: My own thing is that you should be telling patients right from the get-go that they have incurable diseases and not letting them meander along thinking that we can actually help cure them in some meaningful way. We know who's incurable, and even if they have two or three years of survival coming to them, colorectal cancer or breast and prostate, etc., it's still fair to tell them that we can't cure them. And then when the time does come two, three, four years later, they're not going to be shocked, and they'll deal with it, I think, in a better way because they've known all along that this day is going to come, and then they don't react badly in the last two weeks, three weeks, four weeks, because they've been prepared for all those years before. I think the real problem is no one ever tells them directly, or many doctors don't tell them directly upfront. And so, when it comes near the end, they don't tell them until they're almost semiconscious. Then it's a shock out of the blue. And then of course they want to be treated more aggressively at the end. And I think that's where some of the issues may come. Dr. Holly Prigerson: And with the immunotherapies, that probably raises a lot more questions, even from the oncologist's perspective, about what they can call incurable because maybe there is hope, maybe there are these outliers. That's where it seems like it's wonderful that there are advances, but if the rates are so low and people have a misunderstanding of their chances, I think we're on the side of understanding what the best data suggests are the likely outcomes. And I think all the new advances sort of undermine disparaging hope because that's what they're there to do. They're there to offer hope. Dr. Shannon Westin: And everybody wants to be the tail of the curve, right? They all want to be that person. So that's exactly—you're totally right. When we're trying to communicate, “Okay, this is the most common outcome.  Yes, there are people that are way over here but…”  Dr. Holly Prigerson: That's going to be me. Dr. Shannon Westin: Yes. They always say, “That's going to be my miracle.” Well, great. Well, thank you both so much. This was such a lively discussion, and I know the listeners learned a ton. I know I did.  Again, thank you all for listening to JCO After Hours. We were discussing "You Get (offered) What You (can) Pay For: Explaining Disparities in End-of-Life Cancer Care," published in the JCO 6/20/23. We're so excited that you took the time to listen. If you're looking for more podcasts, check out our website, or you can find us wherever you get your podcasts. Have a wonderful day. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

#35: Household Chemicals and Their Risks with Jeanne Schumacher This is part 2 of our interview with Dr. Schumacher about household chemicals and their risks. Jeanne Schumacher, M.Ed., Ed.D has earned her doctorate in science and education and has taught for over 35+ years. She is a firm believer in “walking the walk.” She is committed to inspiring people to change their health destiny through a non-toxic whole food, plant-based lifestyle. She is passionate about making a difference in the lives of others by teaching practical ways to improve their health. She believes that food is our best medicine and helps us get our bodies back to a state of health when faced with “dis”-ease. She has been sharing her knowledge through motivational and educational lectures as well as on her website www.SimplyPlantBased.net In 2020, Drs. Shapiro and Schumacher launched The Pregnancy Advantage, to help women get their bodies pregnant-ready or help if they have trouble conceiving. (www.PregnancyAdvantage.net) In 2022, Dr. Schumacher launched The Plant Based Academy, to help provide education, support, and guidance to people who want to live a whole food plant-based lifestyle. (www.PlantBasedAcademy.net). Jeanne has followed a plant-based diet since 2009 and has become a motivational speaker and educator on whole food, plant-based living as well as living without toxins. Her transformation to a healthier lifestyle began with a trip to the emergency room with a 105-degree fever, deadly high blood pressure, and an unknown infection. Luckily, the physician who attended her was not only trained in medicine but also in nutrition. This doctor started Jeanne on a journey that would not only change her health destiny but her life as well. Jeanne has successfully earned her Plant-Based Nutrition Certificate through Cornell - Center for Nutritional Studies and completed the Women's Studies and Food Over Medicine program through the Wellness Forum. Today, We Discussed: 00:58 - 4:17 Pulling Back The Curtain 4:18 - 6:30 What Helps Get Rid of Toxins? 6:31 - 8:03 Where Do You Start? 20:58 - 22:02 Why It Is So Important to Be Aware of These Chemicals? 23:47 - 26:40 What's The Endgame? Learn More About Harmful Toxic Ingredients: https://bit.ly/43Y6rsz Listen and Subscribe Facebook: https://www.facebook.com/pbnm.org/ Instagram: https://www.instagram.com/pbnmorg/ Youtube: https://www.youtube.com/channel/UCrHajqYAnc6b0syopySVkOg/ #nutrition #nutritiontips #nutritionfacts #nutritionstudent #educatorsmindset #educator #plantbased #plantbasedfood #plantbasedlife #plantbasedlifestyle

Jeanne Schumacher, M.Ed., Ed.D has earned her doctorate in science and education and has taught for over 35+ years. She is a firm believer in “walking the walk.” She is committed to inspiring people to change their health destiny through a non-toxic whole food, plant-based lifestyle. She is passionate about making a difference in the lives of others by teaching practical ways to improve their health. She believes that food is our best medicine and helps us get our bodies back to a state of health when faced with “dis”-ease. She has been sharing her knowledge through motivational and educational lectures as well as on her website www.SimplyPlantBased.net In 2020, Drs. Shapiro and Schumacher launched The Pregnancy Advantage, to help women get their bodies pregnant-ready or help if they have trouble conceiving. (www.PregnancyAdvantage.net) In 2022, Dr. Schumacher launched The Plant Based Academy, to help provide education, support, and guidance to people who want to live a whole food plant-based lifestyle. (www.PlantBasedAcademy.net). Jeanne has followed a plant-based diet since 2009 and has become a motivational speaker and educator on whole food, plant-based living as well as living without toxins. Her transformation to a healthier lifestyle began with a trip to the emergency room with a 105-degree fever, deadly high blood pressure, and an unknown infection. Luckily, the physician who attended her was not only trained in medicine but also in nutrition. This doctor started Jeanne on a journey that would not only change her health destiny but her life as well. Jeanne has successfully earned her Plant-Based Nutrition Certificate through Cornell - Center for Nutritional Studies and completed the Women's Studies and Food Over Medicine program through the Wellness Forum. Today, We Discussed: 8:05 - 8:56 How Triclosans Affect the Endocrine System 14:41 - 16:37 Strengthening Immune Response 18:08 - 19:46 The Risks of Fragrances 19:50 - 22:07 Changing Behavior For Pregnancy Learn More About Harmful Toxic Ingredients: https://bit.ly/43Y6rsz Listen and Subscribe Facebook: https://www.facebook.com/pbnm.org/ Instagram: https://www.instagram.com/pbnmorg/ Youtube: https://www.youtube.com/channel/UCrHajqYAnc6b0syopySVkOg/ #nutrition #nutritiontips #nutritionfacts #nutritionstudent #educatorsmindset #educator #plantbased #plantbasedfood #plantbasedlife #plantbasedlifestyle

For almost three years the amount of aid provided to low-income families increased. In response to the COVID-19 pandemic, additional benefit allotments allowed SNAP households to receive more money in monthly benefits per person. But as of March 1st, those benefits are gone nationwide.  We look back at our conversation with Jamila Michener, associate professor in the department of Government at Cornell University, Co-Director of the Cornell Center for Health Equity, and Author of, Fragmented Democracy: Medicaid, Federalism, and Unequal Politics. 

For almost three years the amount of aid provided to low-income families increased. In response to the COVID-19 pandemic, additional benefit allotments allowed SNAP households to receive more money in monthly benefits per person. But as of March 1st, those benefits are gone nationwide.  We look back at our conversation with Jamila Michener, associate professor in the department of Government at Cornell University, Co-Director of the Cornell Center for Health Equity, and Author of, Fragmented Democracy: Medicaid, Federalism, and Unequal Politics. 

This episode is an abridged version of the previous episode, picking up the story from the time Professor Babcock entered academia, and quickly focusing on the fascinating and important work she and her students have done and continue to do in the African country of Malawi. You can learn more about Professor Babcock and the work of the Cornell Center on the Death Penalty Worldwide here and here.You can read about the recent success of the Cornell Law School International Human Rights Clinic in Malawi here.You can learn more about the Cornell Law School Death Penalty Program here, and find the short video mentioned in the podcast here.You can find the NY Times photograph that inspired Professor Babcock to begin her work in Malawi here. (May require a NY Times subscription).

Malawi is a landlocked country in southeastern Africa. It is one of the poorest countries in the world. Like many countries, Malawi still applies the death penalty for capital crimes, although the death penalty is no longer mandatory in capital cases and may be abolished entirely in Malawi soon. Several years ago, a law professor named Sandra Babcock took an interest in the Malawi penal system after seeing a New York Times article about horrific prison conditions there. Having spent much of her early career representing persons awaiting execution in American prisons, Professor Babcock, then at Northwestern Law School, arranged to bring six of her students to Malawi to see how they might help Malawian prisoners subjected to those conditions, many of whom had no lawyer and were still awaiting trial after years of incarceration. That first trip resulted in the release of 12 incarcerated persons, and marked the beginning of a multi-year project Professor Babcock led, first at Northwestern and later at Cornell Law School. Today the Cornell Center on the Death Penalty Worldwide that Professor Babcock leads continues to assist Malawian prisoners, and has extended its work to Tanzania, with a focus on representing women on death row in that country. I recently had the pleasure of talking with Professor Babcock about the public defense and death penalty work she performed before becoming a law professor, and the extraordinary work she and her students have done and continue to do on behalf of Malawians on death row. You can learn more about Professor Babcock and the work of the Cornell Center on the Death Penalty Worldwide here and here.You can read about the recent success of the Cornell Law School International Human Rights Clinic in Malawi here.You can learn more about the Cornell Law School Death Penalty Program here, and find the short video mentioned in the podcast here.You can find the NY Times photograph that inspired Professor Babcock to begin her work in Malawi here. (May require a NY Times subscription).

SNAP or the Supplemental Nutrition Assistance Program, is one of the most critical policy tools we have to address hunger and poverty in the U-S. And during the pandemic, it was a literal lifeline.  Congress temporarily increased SNAP benefits giving a boost of 15 percent to everyone who needed it and allowing all families to max out their eligibility based on the size of the family.  This month, the nearly three-year boost to a benefit used by more than 41 million Americans will end.  And now that a carton of eggs costs about as much as college tuition, millions of families will have to stretch their food dollars even further. It's a tough blow, especially given Child Tax Credit, expanded for the pandemic, was also allowed to expire.   Data from the Brookings Institute show that those monthly checks of up to $300 dollars per child lifted more than 3 and a half million children out of poverty. Something the Biden Administration was very proud of.  We speak with Jamila Michener, associate professor of Government at Cornell University. Co-Director of the Cornell Center for Health Equity, and Author of Fragmented Democracy: Medicaid, Federalism and Unequal Politics.  

SNAP or the Supplemental Nutrition Assistance Program, is one of the most critical policy tools we have to address hunger and poverty in the U-S. And during the pandemic, it was a literal lifeline.  Congress temporarily increased SNAP benefits giving a boost of 15 percent to everyone who needed it and allowing all families to max out their eligibility based on the size of the family.  This month, the nearly three-year boost to a benefit used by more than 41 million Americans will end.  And now that a carton of eggs costs about as much as college tuition, millions of families will have to stretch their food dollars even further. It's a tough blow, especially given Child Tax Credit, expanded for the pandemic, was also allowed to expire.   Data from the Brookings Institute show that those monthly checks of up to $300 dollars per child lifted more than 3 and a half million children out of poverty. Something the Biden Administration was very proud of.  We speak with Jamila Michener, associate professor of Government at Cornell University. Co-Director of the Cornell Center for Health Equity, and Author of Fragmented Democracy: Medicaid, Federalism and Unequal Politics.  

Three years into the pandemic and yet another new variant of the coronavirus has emerged. The omicron subvariant known as XBB.1.5 now accounts for more than 40% of new COVID infections in the U.S. and around 75% of cases in the Northeast. Dr. Jay Varma of the Cornell Center for Pandemic Prevention and Response joined William Brangham to discuss the concerns. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Three years into the pandemic and yet another new variant of the coronavirus has emerged. The omicron subvariant known as XBB.1.5 now accounts for more than 40% of new COVID infections in the U.S. and around 75% of cases in the Northeast. Dr. Jay Varma of the Cornell Center for Pandemic Prevention and Response joined William Brangham to discuss the concerns. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Join Fr. Gregory Pine, O.P. of Aquinas 101, Godsplaining, and Pints with Aquinas for an off-campus conversation with Prof. Jonathan Lunine about his latest Thomistic Institute lecture, "Catholicism and Evolution from an Astronomical Perspective.” Catholicism and Evolution w/ Fr. Gregory Pine (Off-Campus Conversations) You can listen to the original lecture here: https://soundcloud.com/thomisticinstitute/evolution-and-catholicism-from-an-astronomical-perspective-prof-jonathan-lunine For more information on upcoming events, please visit www.thomisticinstitute.org. About the speaker: Jonathan I. Lunine is The David C. Duncan Professor in the Physical Sciences at Cornell University and Director of the Cornell Center for Astrophysics and Planetary Science, His research focuses on astrophysics, planetary science and astrobiology. In addition to his responsibilities in the classroom, he serves as Interdisciplinary Scientist on the James Webb Space Telescope project and is a coinvestigator on the Juno mission currently in orbit around Jupiter. Lunine is a member of the U.S. National Academy of Sciences, a fellow of the American Geophysical Union and the American Association for the Advancement of Science. He is the 2014 recipient of the Jean Dominique Cassini Medal of the European Geosciences Union. He is the author of Astrobiology: A Multidisciplinary Approach and Earth: Evolution of a Habitable World. Lunine obtained a B.S. in physics and astronomy from the University of Rochester (1980), an M.S. (1983) and a Ph.D. (1985) in planetary science from the California Institute of Technology. He lives in Ithaca New York, where he is a member of St. Catherine of Siena parish. In 2016 Lunine helped to found the Society of Catholic Scientists and currently serves as its vice president.

Prof. Lunine's slides can be viewed here: https://tinyurl.com/4fce6w7w This talk was given on October 6, 2022, at the University of Rochester. For more information, please visit thomisticinstitute.org. About the speaker: Jonathan I. Lunine is The David C. Duncan Professor in the Physical Sciences at Cornell University and Director of the Cornell Center for Astrophysics and Planetary Science, His research focuses on astrophysics, planetary science and astrobiology. In addition to his responsibilities in the classroom, he serves as Interdisciplinary Scientist on the James Webb Space Telescope project and is a coinvestigator on the Juno mission currently in orbit around Jupiter. Lunine is a member of the U.S. National Academy of Sciences, a fellow of the American Geophysical Union and the American Association for the Advancement of Science. He is the 2014 recipient of the Jean Dominique Cassini Medal of the European Geosciences Union. He is the author of Astrobiology: A Multidisciplinary Approach and Earth: Evolution of a Habitable World. Lunine obtained a B.S. in physics and astronomy from the University of Rochester (1980), an M.S. (1983) and a Ph.D. (1985) in planetary science from the California Institute of Technology. He lives in Ithaca New York, where he is a member of St. Catherine of Siena parish. In 2016 Lunine helped to found the Society of Catholic Scientists and currently serves as its vice president.

The Smart 7 Ireland Edition is the daily news podcast that gives you everything you need to know in 7 minutes, at 7am, 7 days a week… Consistently appearing in Ireland's Daily News charts, we're a trusted source for people every day. If you're enjoying it, please follow, share or even post a review, it all helps… Today's episode includes references to the following guests: Dr Emer MacSweeney - CEO and Medical Director at Re:Cognition HealthSian Gregory - Research Information Manager at the Alzheimers SocietyFaye Couceiro - Reader in Biogeochemistry & Environmental Pollution at the University of PortsmouthProfessor Shaji Sebastian - Consultant Gastroenterologist at Hull UniversityMakalea Ane - Community Engagement Lead at the Nature ConservancyCaroline Smith - Head of Earth Sciences Collections at the Natural History MuseumDr. Jay Varma - Director of the Cornell Center for Pandemic Prevention and Response at Weill Cornell MedicineDr Sam Parnia - Associate Professor of Critical Care Medicine and Director of Critical Care and Resuscitation Research at NYU School of MedicineProfessor Paul Barrett - Head of Fossil Vertebrates at the Natural History Museum Contact us over at Twitter or visit www.thesmart7.com Presented by Ciara Revins, written by Oliva Davies and Liam Thompson and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

The Smart 7 is a daily podcast that gives you everything you need to know in 7 minutes, at 7 am, 7 days a week... With over 11 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day. If you're enjoying it, please follow, share, or even post a review, it all helps... Today's episode includes the following guests: Dr Emer MacSweeney - CEO and Medical Director at Re:Cognition HealthSian Gregory - Research Information Manager at the Alzheimers SocietyFaye Couceiro - Reader in Biogeochemistry & Environmental Pollution at the University of PortsmouthProfessor Shaji Sebastian - Consultant Gastroenterologist at Hull UniversityMakalea Ane - Community Engagement Lead at the Nature ConservancyCaroline Smith - Head of Earth Sciences Collections at the Natural History MuseumDr. Jay Varma - Director of the Cornell Center for Pandemic Prevention and Response at Weill Cornell MedicineDr Sam Parnia - Associate Professor of Critical Care Medicine and Director of Critical Care and Resuscitation Research at NYU School of MedicineProfessor Paul Barrett - Head of Fossil Vertebrates at the Natural History MuseumIn Ireland? Why not try our Ireland Edition?Contact us over at Twitter or visit www.thesmart7.comPresented by Jamie East, written by Olivia Davies and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

This talk was given on October 14, 2022 at the Dominican House of Studies for the 2022 Fall Thomistic Circles conference: Life in the Cosmos: Contemporary Science, Philosophy, and Theology on the Origin and Persistence of Life on Earth (and Beyond?). Prof. Lunine's slides may be viewed here: https://tinyurl.com/22vs3mdv For more information, please visit thomisticinstitute.org. About the speaker: Jonathan I. Lunine is The David C. Duncan Professor in the Physical Sciences at Cornell University and Director of the Cornell Center for Astrophysics and Planetary Science, His research focuses on astrophysics, planetary science and astrobiology. In addition to his responsibilities in the classroom, he serves as Interdisciplinary Scientist on the James Webb Space Telescope project and is a coinvestigator on the Juno mission currently in orbit around Jupiter. Lunine is a member of the U.S. National Academy of Sciences, a fellow of the American Geophysical Union and the American Association for the Advancement of Science. He is the 2014 recipient of the Jean Dominique Cassini Medal of the European Geosciences Union. He is the author of Astrobiology: A Multidisciplinary Approach and Earth: Evolution of a Habitable World. Lunine obtained a B.S. in physics and astronomy from the University of Rochester (1980), an M.S. (1983) and a Ph.D. (1985) in planetary science from the California Institute of Technology. He lives in Ithaca New York, where he is a member of St. Catherine of Siena parish. In 2016 Lunine helped to found the Society of Catholic Scientists. About the conference: What is life? How did biological life arise? What makes life persist and might it exist elsewhere in the cosmos? What would that mean? Consider these questions and more with the Thomistic Institute at the Fall Thomistic Circles conference, Life in the Cosmos: Contemporary Science, Philosophy, and Theology on the Origin and Persistence of Life on Earth (and Beyond?). The two-day conference at the Dominican House of Studies in Washington, D.C. features a stellar, cross-disciplinary lineup of speakers, scientists Jonathan Lunine (Cornell University) and Maureen Condic (University of Utah), philosopher Christopher Frey (University of South Carolina), and theologian Fr. Mauriusz Tabaczek, O.P. (Angelicum). This conference is part of the Thomistic Institute's Scientia Project.

Carlos Bustamante, over the past 15 years, has led a multidisciplinary team working on problems at the interface of computational and biological sciences. Much of his research has focused on genomics technology and its application in medicine, agriculture, and evolutionary biology. His first academic appointment was at Cornell University's College of Agriculture and Life Sciences. There, much of his work focused on population genetics and agricultural genomics motivated by a desire to improve the foods we eat and the lives of the animals upon which we depend. He moved to Stanford in 2010, to focus on enabling clinical and medical genomics on a global scale. He has been particularly focused on reducing health disparities in genomics by: (1) calling attention to the problem raised by >95% of participants in large-scale studies being of European descent; and (2) broadening representation of understudied groups, particularly U.S. minority populations and those from Latin America. Taken together, this work has empowered decision-makers to utilize genomics and data science in the service of improving human health and wellbeing. As Inaugural Chair of Stanford's new Department of Biomedical Data Science, his future goal is to scale these operations from focusing on researchers to consumers and patients, where we ultimately want our work to have the greatest impact.In 2017, Bustamante was appointed a Chan-Zuckerberg Investigator and, from 2011–2016, he was a MacArthur Fellow. He also received a Stanford Prize in Population Genetics and Society in 2016, a Sloan Research-Fellowship in Molecular Biology from 2007–2009, and a Marshall-Sherfield Fellowship from 2001–2002. Bustamante also has a strong interest in building new academic units, non-profits, and companies. He is Founding Director (with Marcus Feldman) of the Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG), and former Founding Associate Director of the Cornell Center for Comparative and Population Genomics (3CPG).He serves as an advisor to the US federal government, private companies, startups, and non-profits in the areas of computational genomics, population and medical genetics, and veterinary and plant genomics. He is currently Director of EdenRoc Sciences, Founder @ Arc Bio, & an SAB member of: Embark Veterinary, the Mars/IBM Food Safety Board, & Digitalis Ventures.Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)

With more than 7,000 cases reported in the U.S, the Biden administration has declared monkeypox a public health emergency. The declaration announced Thursday comes after the administration endured weeks of criticism for its response to this outbreak. Dr. Jay Varma, director of the Cornell Center for Pandemic Prevention and Response at Weill Cornell Medicine, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

With more than 7,000 cases reported in the U.S, the Biden administration has declared monkeypox a public health emergency. The declaration announced Thursday comes after the administration endured weeks of criticism for its response to this outbreak. Dr. Jay Varma, director of the Cornell Center for Pandemic Prevention and Response at Weill Cornell Medicine, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Joseph Osmundson, microbiologist, activist, writer, and author of Virology: Essays for the Living, the Dead, and the Small Things in Between (W. W. Norton & Company, 2022) and Jay Varma, physician and epidemiologist, director of the Cornell Center for Pandemic Prevention and Response and professor of Population Health Sciences at Weill Cornell Medicine, share updates on the monkeypox outbreak and the public health response as New York City joins the state in declaring the spread of the virus a public health emergency.

Jay Varma, physician and epidemiologist, director, Cornell Center for Pandemic Prevention and Response, professor of Population Health Sciences at Weill Cornell Medicine talks about the latest wave of cases caused by BA.5, the possibility of an Omicron-specific booster shot this fall and more COVID news.

While cancer screening methods and treatments have improved over the years, there are still significant barriers that prevent access to care for many individuals. Community outreach and engagement can help to combat these health disparities and dismantle myths and stigmas surrounding cancer. Through the help of community health workers and dedicated teams, efforts are underway to bring health equity issues to the forefront in healthcare and work towards a better tomorrow with optimal health for all.Guest: Erica Phillips, MD, MS, internal medicine physician at Weill Cornell Medicine, Associate Director of Community Outreach and Engagement at the Sandra and Edward Meyer Cancer Center, and Co-Associate Director of Community Engagement at the Cornell Center for Health Equity.Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

Dr. Gary Koretzky is President of the American Association of Immunologists, Vice Provost for Academic Integration at Cornell University, Professor of Medicine at Weill Cornell Medicine, and Director of the Cornell Center for Immunology. He talks about how he began his career in immunology, using science to guide Cornell's response to COVID-19, and what to expect at AAI's Immunology 2022 meeting taking place May 6-10th.

Jay Varma, physician and epidemiologist, director, Cornell Center for Pandemic Prevention and Response, professor of Population Health Sciences at Weill Cornell Medicine, talks about the expected announcement that unvaccinated athletes will be allowed to play in NYC, including Nets star Kyrie Irving.

Description: Clinton Neill, PhD, assistant professor at Cornell University College of Veterinary Medicine's Center for Veterinary Business and Entrepreneurship, joins Dr. Andy Roark to discuss the economic impact of burnout on the veterinary profession. LINKS: Burnout's Economic Toll on Veterinarians Calculated (JAVMA): https://www.avma.org/javma-news/2021-12-15/burnouts-economic-toll-veterinarians-calculated?utm_source=delivra&utm_medium=email&utm_campaign=JAVMA%20News%20December%2015%202021&utm_id=3330547&utm_term=Read+more&dlv-emuid=c2921e9c-4321-4b95-ba17-70b6e899c404&dlv-mlid=3330547 Uncharted Podcast on iTunes: https://podcasts.apple.com/us/podcast/the-uncharted-veterinary-podcast/id1449897688 WORKSHOP - Loading the Bus w/ Dr. Andy Roark & Stephanie Goss: https://unchartedvet.com/strategic-planning/ UNCHARTED APRIL CONFERENCE: https://unchartedvet.com/uncharted-april-2022/ Charming the Angry Client On-Demand Staff Training: https://drandyroark.com/on-demand-staff-training/ What's on my Scrubs?! Card Game: https://drandyroark.com/training-tools/ Dr. Andy Roark Swag: drandyroark.com/shop All Links: linktr.ee/DrAndyRoark ABOUT OUR GUEST: Bio: Dr. Clinton Neill is currently an Assistant Professor in veterinary economics for the Cornell Center of Veterinary Business and Entrepreneurship. Dr. Neill's research primarily focuses on the broad scope of issues that face the veterinary industry. He also has grant funded research projects in food policy, labeling, and the integration of producer and consumer decision making. Before coming to Cornell, Dr. Neill was an Assistant Professor in Food Systems Economics at Virginia Tech. Dr. Neill completed his bachelor's and master's degrees in Agricultural and Applied Economics at Texas Tech University, and received his Doctorate in Agricultural Economics from Oklahoma State University. In addition to his research Dr. Neill focuses on bringing his academic research to real solutions for the veterinary and food industries. Email: cln64@cornell.edu

This episode's guest is Jamila Michener, Associate Professor at Cornell University. She studies poverty, racism, and public policy, with a particular focus on health and housing. She is author of the award-winning book, Fragmented Democracy: Medicaid, Federalism, and Unequal Politics. She is Associate Dean for Public Engagement at the Brooks School of Public Policy, co-director of the Cornell Center for Health Equity, co-director of the Politics of Race, Immigration, Class and Ethnicity (PRICE) research initiative, and board chair of the Cornell Prison Education Program. Civil law is the channel through which many people adjudicate the (non-criminal) legal challenges that emerge in everyday life. Core functions of civil law involve arbitrating outcomes that are especially vital to people living in or near poverty (e.g., evictions, loss of public assistance, disputes between lenders and borrowers, and much more). Moreover, civil legal protections are especially critical to low-income women of color. This talk will highlight the repercussions of civil legal inequality. Professor Michener will show how civil legal institutions affect economic and political dynamics in race-class subjugated communities. and consider the implications of civil legal institutions for U.S. democracy. Interview by Dartmouth student Shawdi Mehrvarzan '22. Edited by Laura Hemlock. Music: Debussy Arabesque no 1. Composer: Claude Debussy

Dr. Sam Morello is on the podcast to discuss her recent publication in JAVMA, Comparison of resident and intern salaries with the current living wage as a quantitative estimate of financial strain among postgraduate veterinary trainees. Dr. Morello makes the case that early career pay plays a role in our ability to increase diversity in the profession, support women and families, reduce the frequency of burnout and increase doctor retention in the clinical space. LINKS: Original Article: https://avmajournals.avma.org/view/journals/javma/aop/javma.21-07-0336/javma.21-07-0336.xml Uncharted Podcast on iTunes: https://podcasts.apple.com/us/podcast/the-uncharted-veterinary-podcast/id1449897688 Charming the Angry Client On-Demand Staff Training: https://drandyroark.com/on-demand-staff-training/ What's on my Scrubs?! Card Game: https://drandyroark.com/training-tools/ Dr. Andy Roark Swag: drandyroark.com/shop All Links: linktr.ee/DrAndyRoark ABOUT OUR GUEST: Sam Morello received her BS and DVM from Cornell University and completed a large animal surgical residency at the University of Pennsylvania's New Bolton Center. She spent over a decade in academia as an Associate Professor Surgery focused on musculoskeletal and upper airway diseases. In addition to her clinical research on those topics, Dr. Morello has extensive experience investigating and speaking on professional sustainability, economic, and personal life issues in veterinary medicine with a particular focus on gender. She has been an invited speaker nationally and internationally and at veterinary schools across the country. Projects have focused on women and other underrepresented groups in veterinary surgery and human orthopedics, on work-life issues for veterinarians, residency-selection and compensation, and how gender stereotypes affect perceptions of veterinary medicine to those outside. Her goals are to provide data to improve mentorship, inform career decisions, and to guide those in management and leadership roles to shape the policies that best serve the profession. She serves as the Assistant Director for Continuing Education for the American College of Veterinary Surgeons, a member of the AOVet North America Faculty where she serves on the Education Committee and leads a task force on Faculty and Leader Development for the internationally run AO Access program, a program she helped to design and launch dedicated to improving diversity, opportunity, and mentorship among global community of human and veterinary orthopedic surgeons. She also serves on the board for the Women's Veterinary Leadership Development Initiative. Sam is now self employed as a consultant, based in Madison, Wisconsin, and recently joined the Cornell Center for Veterinary Business and Entrepreneurship as a Courtesy Associate Professor.

On this weeks episode Justine and Amanda sit down with Chelsea Halstead,  the Associate Director of the Cornell Center on the Death Penalty Worldwide, where she oversees the center's strategy, advocacy, and fundraising efforts.We discuss how women are treated when it comes to the death penalty, some stories of women from death row, some projects Cornell Center on the Death Penalty Worldwide is working on, and more. To learn more about Cornell Center on the Death Penalty Worldwide:https://deathpenaltyworldwide.org/To learn more about The Alice Project:https://deathpenaltyworldwide.org/project/the-alice-project/

We are joined by Lori Leonard, Amy Kuo Somchanhmavong, and Shorna Allred, members of the Cornell Center for Teaching Innovation's Digital Storytelling Community of Practice. We learn about the podcasts, video stories, and other media projects they are utilizing in the classroom and the field. #加油 #boleh #dounia  #perema Center for Teaching Innovation - Digital Storytelling Community of Practice Global Garbage - Trash Talk Global Citizenship and Sustainability Digital Stories

This lecture was delivered on June 18, 2021 as part of the third annual Thomistic Philosophy and Natural Science Symposium: Chance and Indeterminacy in the Natural World. For information on upcoming events, please visit our website at www.thomisticinstitute.org. About the speaker: Jonathan I. Lunine is The David C. Duncan Professor in the Physical Sciences at Cornell University and Director of the Cornell Center for Astrophysics and Planetary Science, His research focuses on astrophysics, planetary science and astrobiology. In addition to his responsibilities in the classroom, he serves as Interdisciplinary Scientist on the James Webb Space Telescope project and is a coinvestigator on the Juno mission currently in orbit around Jupiter. Lunine is a member of the U.S. National Academy of Sciences, a fellow of the American Geophysical Union and the American Association for the Advancement of Science. He is the 2014 recipient of the Jean Dominique Cassini Medal of the European Geosciences Union. He is the author of Astrobiology: A Multidisciplinary Approach and Earth: Evolution of a Habitable World. Lunine obtained a B.S. in physics and astronomy from the University of Rochester (1980), an M.S. (1983) and a Ph.D. (1985) in planetary science from the California Institute of Technology. He lives in Ithaca New York, where he is a member of St. Catherine of Siena parish. In 2016 Lunine helped to found the Society of Catholic Scientists and currently serves as its vice president.

In January this year, the only woman on federal death row Lisa Montgomery, was given a lethal injection. Since then, there's been changes to federal executions in the US and people have spoken out about failings in the case against her. We revisit an episode where host Noel Phillips is joined by members of Lisa Montgomery's legal campaign. He talks to Sandra Babcock, who is clinical professor at Cornell Law School and the faculty director of the Cornell Center on the Death Penalty Worldwide, along with Leigh Goodmark, professor of law and director of the Gender Violence Clinic at the University of Maryland, and J.D. Gordon, a former senior policy adviser to Donald Trump. This podcast contains graphic details of violence and sexual abuse that some listeners may find distressing.

Patricia Thomson, nutritionist, speaker, cancer survivor, shares her cancer story and how eating a whole-food, plant-based diet was key in her wellness journey.Patricia R. Thomson, Ph.D., aka Dr. T, is the author of WFPB20 (Whole Food Plant Based) and the Food as Medicine Five Day Lifestyle Plan, a certified nutritionist, an experienced speaker, Events Director, coach, consultant, and cancer survivor. As the co-founder of Wellness20, Dr. T is on a mission to create thriving communities around the world. She earned her nutrition certificate through e-Cornell Center for Nutrition Studies, her plant-based culinary certification through the Rouxbe Culinary School, and her teaching certification through the Physicians Committee For Responsible Medicine Food For Life program.Dr. T has taught courses in employee wellness, disease prevention, and reversal for heart disease, cancer, diabetes, Alzheimer's, in addition to weight loss management, food addiction, thyroid and hormone control, digestive disorders, and kid's health. She has worked extensively with nonprofit organizations in helping to raise awareness for a variety of compelling causes.She is the co-Founder of the VIRTUAL Food As Medicine Summit & EXPO event which featured world-renowned nutrition experts, health & wellness exhibitors, and local wellness practitioners to share the state-of-the-science on health and nutrition and the practicalities and life-changing impacts of using food as medicine.Patricia has been in the nonprofit industry for over 25 years serving as the CEO/Executive Director of several national and international organizations. She has developed, implemented, and oversaw the operations of dozens of public and private events including races, climbs, walks, fashion shows, auctions, markets, fairs, dinners, luncheons, exclusive donor events, and conferences, to name a few. These events raised millions of dollars and involved thousands of attendees at a time. Patricia is a published scientist, has a Ph.D. in Biological Sciences, with a focus on toxicology, and has worked in both the private and public sectors protecting human and environmental health.Follow Dr. T on Instagram: @WellnessTwentySee her website: www.wellness-20.comFollow her on Facebook: WellnessTwentyFinish Your Racehttps://businessinnovatorsradio.com/finish-your-race/Source: https://businessinnovatorsradio.com/patricia-thomson-nutritionist-speaker-cancer-survivor-on-eating-a-whole-food-plant-based-diet

Speaker: Jessica Chen Weiss, Associate Professor of Government, Cornell University How does China’s domestic governance shape its foreign policy? What role do nationalism and ideology play in Beijing’s regional and global ambitions? The Chinese leadership has been at once a revisionist, defender, reformer, and free-rider in the international system—insisting rigidly on issues that are central to its domestic survival while showing flexibility on issues that are more peripheral. To illuminate this variation and prospects for conflict and cooperation, Weiss will discuss her new book project, which theorizes and illustrates the domestic-international linkages in Beijing’s approach to issues ranging from sovereignty and homeland disputes to climate change and COVID-19. Jessica Chen Weiss is Associate Professor of Government at Cornell University. She is the author of Powerful Patriots: Nationalist Protest in China’s Foreign Relations (Oxford University Press, 2014). The dissertation on which it is based won the 2009 American Political Science Association Award for best dissertation in international relations, law, and politics. Her work has appeared or is forthcoming in International Organization, China Quarterly, Journal of Conflict Resolution, and Security Studiesopens pdf file. Her research has been supported by the National Science Foundation, Cornell Einaudi Center, Cornell Center for Social Sciences, Uppsala University, Princeton-Harvard China & The World Program, Bradley Foundation, Fulbright-Hays program, and University of California Institute on Global Conflict and Cooperation. Born and raised in Seattle, Washington, Weiss received her Ph.D. from the University of California, San Diego. Before joining Cornell, she was an assistant professor at Yale University (2009-2015) and founded FACES, the Forum for American/Chinese Exchange at Stanford, while an undergraduate at Stanford University. Learn more about her research and writing at www.jessicachenweiss.com.

Perseverance and Ingenuity. Sometimes it's all about alignment. It just so happens that this planetary alignment happened in the middle of a global pandemic. Mars reached opposition in October 2020, a "mere" 38.6 million miles away from Earth. A rare opportunity to launch a rover seeking signs of ancient life to collect samples of rock and regolith (broken rock and soil) for a possible return to Earth. So, the many scientists and engineers involved in the Mars 2020 Mission persevered, finding ways to continue their innovative work and successfully launch the Perseverance Rover on July 30, 2020.On February 18, 2021, it landed. Now, more than 144 million miles away, this amazing technology is sending back incredible images of the red planet. Next up, the Mars Helicopter, Ingenuity, will test powered flight on another world for the first time.This week we're talking about this spectacular accomplishment, one that sparks the imagination about humankind's capacity for perseverance and ingenuity, with Rob Sullivan, Principal Research Scientist at the Cornell Center for Astrophysics and Planetary Science, and Co-Investigator with Mastcam-Z and MEDA on the Mars 2020 mission.

Something unbelievably awful was about to happen to Bobbie Jo Stinnett. She was about to live a nightmare. But the nightmare was already with Lisa Montgomery, swirling around her, never letting up. The nightmare had molded her, turning her into the sort of person that would knock on Bobbie Jo’s door with a knife beneath her jacket.  *** SUPPORT THE PODCAST! Become a Patreon supporter. Purchase THE UNQUIET ENGLISHMAN from this episode’s sponsor, W. W. Norton. And you can preorder my new book Confident Women here, and listen to Red Flags (my latest podcast project) here.*** Sources: “The Tortured Life and Tragic Crime of the Only Woman on Death Row,” 10 Nov 2020, The Huffington Post “My Sister, Lisa Montgomery, Took a Life. Her Own Was Scarred by Unimaginable Abuse. Spare Her,” 19 Nov 2020, Newsweek “Punch After Punch, Rape After Rape, a Murderer Was Made,” 18 Dec 2020, New York Times “Lisa Montgomery, a Kansan who cut a baby from a mother's womb, was executed by the federal government. Here is her story.” 13 Jan 2021, Topeka Capital-Journal “The Case of Lisa Montgomery,” Cornell Center on the Death Penalty Worldwide “Execution date rekindles memories in Skidmore,” 24 Oct 2020, News-Press Now “Accused woman’s relatives say warnings were ignored,” 10 Jan 2005, The Associated Press “Arrest made in death of pregnant woman,” 18 Dec 2004, The Standard “Fateful Day When Butcher Met Victim,” 21 Dec 2004, New York Post “Order Granting Motion to Stay Execution Pending A Competence Hearing,” 11 Jan 2021 “Inside the Race To Save The Only Woman On Federal Death Row,” 8 Jan 2021, The Huffington Post “PETITION FOR EXECUTIVE CLEMENCY ON BEHALF OF LISA MARIE MONTGOMERY PRESENTED TO PRESIDENT DONALD J. TRUMP, DECEMBER 24, 2020” (prepared by Lisa’s lawyers) “U.S. Executes Lisa Montgomery for 2004 Murder,” 13 Jan 2021, New York Times Tweets from journalist Liliana Segura and Michael Tarn, who were at Terre Haute January 12-13, 2021 Music: Intro and conclusion: “Guilty” by Richard A. Whiting, Harry Akst, and Gus Kahn, sung by Anna Telfer  Ad break:  “The Great One Step” by Victor Dance Orchestra, via Free Music Archive, licensed under Public Domain Mark 1.0 Narration music: Stereodog Productions (Dan Pierson & Peter Manheim) Learn more about your ad choices. Visit megaphone.fm/adchoices

Just a warning, this podcast contains graphic details of violence and sexual abuse that some listeners may find distressing. The Trump administration has carried out the most federal executions for 130 years. After a 17-year hiatus, the president had them resumed in July 2020. Since then, the US government has applied the death penalty to 10 people. On Tuesday 12 January, the only woman on federal death row, Lisa Montgomery, is scheduled to be killed by lethal injection. If this goes ahead, she will be the first woman to be put to death by the federal government in 70 years. In this episode of the Sky News Daily podcast, host Noel Phillips is joined by members of Lisa Montgomery's legal campaign. To explain why the president is pursuing these federal executions, he talks to Sandra Babcock, who is clinical professor at Cornell Law School and the faculty director of the Cornell Center on the Death Penalty Worldwide, along with Leigh Goodmark, professor of law and director of the Gender Violence Clinic at the University of Maryland, and J.D. Gordon, a former senior policy adviser to Donald Trump.

Just a warning, this podcast contains graphic details of violence and sexual abuse that some listeners may find distressing. The Trump administration has carried out the most federal executions for 130 years. After a 17-year hiatus, the president had them resumed in July 2020. Since then, the US government has applied the death penalty to 10 people. On Tuesday 12 January, the only woman on federal death row, Lisa Montgomery, is scheduled to be killed by lethal injection. If this goes ahead, she will be the first woman to be put to death by the federal government in 70 years. In this episode of the Sky News Daily podcast, host Noel Phillips is joined by members of Lisa Montgomery's legal campaign. To explain why the president is pursuing these federal executions, he talks to Sandra Babcock, who is clinical professor at Cornell Law School and the faculty director of the Cornell Center on the Death Penalty Worldwide, along with Leigh Goodmark, professor of law and director of the Gender Violence Clinic at the University of Maryland, and J.D. Gordon, a former senior policy adviser to Donald Trump.

In this episode, Dr. Susana Morales talks about how her deep roots in activism and her family played a pivotal role in her journey. Like our other leaders this season, she provides her perspective in this time, discussing opportunities around diversity and health equity for leaders. Along the way, she also reflects on her early mentors and the mentoring models she developed for her current work and initiatives.Dr. Susana Morales is the Vice Chair for Diversity for in the Department of Medicine at Weill Cornell Medicine. She is Associate Professor of Clinical Medicine and directs a newly formed diversity center of excellence at Cornell Center for Health Equity, and she also serves as Associate Program Director of Internal Medicine Training Program at Cornell. TIMESTAMPS: Intro (00:00) | Quote (01:34) | Leadership Journey (02:12) | Diversity, Health Equity & Opportunities (09.41) | Mentorship (13:22) | Accomplishments (22:27) | Self-Care (25:53) | Advice for Younger Self (30:14)| Current Read and Favorite Leadership Book (34:40)Follow Dr. Morales on social media:Twitter: @SusanaMoralesM8

Cornell Law School's Sandra Babcock and Jindal Global Law School's Khagesh Gautam join us for an episode on the death penalty in India and the United States. More than a 100 countries have abolished the death penalty. Both India and the United States are not on that list.  We discuss the state of the death penalty today, cover some contemporary debates, and ask the most important question: Do we even need it?Follow the Cornell Center on the Death Penalty Worldwide to learn more!

Tanner Knorr manages EplerWood International’s new business, develops the newsletter, and continues to build a presence for the company via public relations, social media, and events. Tanner holds a Bachelor’s in Archaeology and a Master’s in Administrative Studies, concentrating in Economic Development and Tourism Management from Boston University. He was also a Teaching Assistant at Harvard Extension. He owns a business called Off Season Adventures that strives for sustainable tourism practices in Tanzania, Ethiopia, Tunisia, Uganda, Rwanda, and Nepal, and is the President of Second Look Worldwide, a 501(c)(3) organization that sponsors infrastructure improvements around tourism destinations in the developing world. In this episode of Destination on the Left, Tanner Knorr, the Program Manager at EplerWood International and the Founder of Off Season Adventures, joins us to talk about Destinations at Risk: The Invisible Burden of Tourism. He discusses the impact of crisis scenarios and overtourism on destinations, and explains what we can do to manage unaccounted for destination costs to provide local infrastructure and protection of eco and sociocultural systems for tourism and local people. What You Will Learn in This Episode: How to access The Invisible Burden Report, a report that helps destinations uncover and account for hidden costs to protect and manage vital assets worldwide Why The Invisible Burden Report can help DMOs support responsible tourism growth The primary goal of The Invisible Burden Report and how it came about Who was involved in the collaborative effort it took for The Invisible Burden Report to materialize The individual subsectors of a destination that are affected by overtourism Phase two of the research report and what we can expect to see The key findings of last year’s research report The concept of holistic accounting and how it works Collaboration in a Time of Crisis Tanner Knorr is the Program Manager at EplerWood International and Owner and Founder of Off Season Adventures. He is a self-proclaimed sustainable tourism entrepreneur who is dedicated to making infrastructure improvements around tourism destinations in the developing world. Through our conversation, Tanner discusses the recently-released research study, Destinations at Risk: The Invisible Burden of Tourism. At a time when our industry is in turmoil due to the impacts of the global pandemic, there is an opportunity to open our minds to new ideas and possibilities. Download the research report and start understanding what we can do to support responsible tourism growth. The Invisible Burden The Destinations at Risk: The Invisible Burden of Tourism report was put together by EplerWood International, the Cornell Center for Sustainable Global Enterprise and The Travel Foundation in the UK. The main goal of this report is to uncover the “invisible burden” of tourism which Tanner defines as the unaccounted for destination costs to provide local infrastructure and protection of eco and sociocultural systems for tourism and local people. It is difficult enough for destinations to find those pieces of the puzzle, so EplerWood International and its collaborators are stepping in to help them manage and finance more efficiently. Overtourism When we talk about The Destinations at Risk: The Invisible Burden of Tourism report, there are a number of different subsectors of a destination that are affected. When tourism populations exceed the populations of the destination, we start to see destinations crack under the weight of it. It affects things like energy, greenhouse gas emissions, water, solid waste, sewage, and other natural and social capital. Tanner Knorr and his associates are working diligently to mitigate the risks of overtourism and manage the issues that have already arisen. Currently, they are working on phase two of The Invisible Burden where they will provide the necessary skills training to people on the ground. Website: http://www.eplerwoodinternational.com/ https://offseasonadventures.com/ Destinations at Risk: The Invisible Burden of Tourism Report: https://www.thetravelfoundation.org.uk/invisible-burden/ LinkedIn: https://www.linkedin.com/in/tanner-c-knorr-40a2a666/ https://www.linkedin.com/company/off-season-adventures-llc/ https://www.linkedin.com/company/eplerwood-international/about/ Facebook: https://www.facebook.com/OffSeasonAdventures Twitter: @tannercknorr @EplerWood

As black holes spiral around each other in the distant universe, Einstein’s theory of general relativity predicts gravitational waves – ripples in the fabric of space-time itself. We have now detected such ripples from stellar-mass black holes, as well as directly imaging a supermassive black hole. Shami Chatterjee, an astronomer at the Cornell Center for Astrophysics and Planetary Science and a member of the NANOGrav collaboration, talks about ongoing efforts to build a Galaxy-scale detector to observe low-frequency gravitational waves from the mergers of supermassive black holes in the distant universe, as well as some of the unexpected discoveries along the way. The unexpected discoveries include enigmatic “fast radio bursts”, bright millisecond flashes of radio waves that pop off thousands of times every day, all over the sky, with astonishing energy output. Dr. Chatterjee searches for and studies neutron stars, and how to use their lighthouse beams as clocks to build a long-wavelength gravitational wave detector. He has done foundational work on fast radio bursts that has been featured twice on the cover of Nature, and plays a small role in the Event Horizon Telescope team that won the 2020 Breakthrough Prize in Fundamental Physics for imaging a black hole. Visit http://g.co/TalksAtGoogle/waves to watch the video.

Cancer patients can make informed treatment decisions if they have a realistic sense of what lies ahead. Guest: Holly Prigerson, PhD, Co-Director of the Cornell Center for Research on End-of-Life Care at Weill Cornell Medicine. Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

Thomas Gilovich is the Irene Blecker Rosenfeld Professor of Psychology at Cornell University and co-director of the Cornell Center for Behavioral Economics and Decision Research. He specializes in the study of everyday judgment and reasoning, psychological well-being, and self-assessment. In addition to his articles in scientific journals, Dr. Gilovich is the author of How We Know What Isn’t So (Free Press), Why Smart People Make Big Money Mistakes (Simon and Schuster, with Gary Belsky), Social Psychology (W.W. Norton, with Dacher Keltner, Serena Chen, and Richard Nisbett), and The Wisest One in the Room (The Free Press, with Lee Ross). Dr. Gilovich is a member of the American Academy of Arts and Sciences and a Fellow of the American Psychological Association, the Association for Psychological Science, the Society of Experimental Social Psychology, and the Society for Personality and Social Psychology. He received his B.A. in Psychology from the University of California at Santa Barbara and his PhD in Psychology from Stanford University. In this episode we dive into the psychology behind why people are happier when they invest in experiences over material possessions. Being one of 4 principles to live by to advance personal happiness, we focus on things people can simply DECIDE to do today, to make themselves happier.

This talk was offered at UC Berkeley on April 8th, 2019. For more information on upcoming TI events, visit: https://thomisticinstitute.org/events/the-search-for-life-beyond-earth Speak Bio: Jonathan I. Lunine is The David C. Duncan Professor in the Physical Sciences at Cornell University and Director of the Cornell Center for Astrophysics and Planetary Science, His research focuses on astrophysics, planetary science and astrobiology. In addition to his responsibilities in the classroom, he serves as Interdisciplinary Scientist on the James Webb Space Telescope project and is a coinvestigator on the Juno mission currently in orbit around Jupiter. Lunine is a member of the U.S. National Academy of Sciences, a fellow of the American Geophysical Union and the American Association for the Advancement of Science. He is the 2014 recipient of the Jean Dominique Cassini Medal of the European Geosciences Union. He is the author of Astrobiology: A Multidisciplinary Approach and Earth: Evolution of a Habitable World. Lunine obtained a B.S. in physics and astronomy from the University of Rochester (1980), an M.S. (1983) and a Ph.D. (1985) in planetary science from the California Institute of Technology. He lives in Ithaca New York, where he is a member of St. Catherine of Siena parish. In 2016 Lunine helped to found the Society of Catholic Scientists and currently serves as its vice president.

Jonathan Lunine, astronomy professor and director, Cornell Center for Astrophysics and Planetary Science at Cornell University, examines the origin of our planet’s water.

Host Jeff Voigt leads an expert panel discussion on the current dynamics surrounding end of life care in the US - is there such a thing as a good death? on The Business of Health Care. Expert Panelists include: Dr. Holly Prigerson, Irving Sherwood Wright Professor of Geriatrics at Weill Cornell Medicine (WCM) and Director of the Cornell Center for Research on End-of-Life Care; Dr. Connie Ulrich, Lillian S. Brunner Chair, Professor of Nursing, and Professor of Bioethics at the University of Pennsylvania's Perelman School of Medicine; and Dr. Philip Pizzo, David and Susan Heckerman Professor and Founding Director of the Stanford Distinguished Careers Institute. Dr. Pizzo co-chaired the National Academy of Medicine 2014 report on Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. See acast.com/privacy for privacy and opt-out information.

The Founding Fathers made sure to put checks in place that would prevent a president from becoming a king. But Professor Larry Jacobs explains that when it comes to foreign policy, the president goes largely unchecked. Next, Professor Frances Lee outlines the ways Congress has rebuked presidential power, even under the current administration. And finally, Professor Keith Whittington takes us to the courts, which have been skeptical of many of President Trump’s executive orders. For More on this Topic: Read Jacobs’ book, Who Governs? Presidents, Public Opinion, and Manipulation Find Lee’s book, Insecure Majorities: Congress and the Perpetual Campaign Check out Whittington’s book, Political Foundations of Judicial Supremacy: The Presidency, the Supreme Court, and Constitutional Leadership in U.S. History Find more on the website for the conference, A Republic, If We Can Keep It, organized by the Cornell Center for the Study of Inequality with lead organizer Suzanne Mettler.

Have you ever wondered why most grocery stores – despite the chain – more or less have the same floor plan? Or why candy bars are always available at the cash register? The layout of stores and strategic placement of certain items is the result of a purposeful decision-making progress designed to encourage people to buy more of one thing or another. Often, the items offered for sale tend to have a lower nutritional value – helping to fuel high levels of obesity and diet related disease prevalent in our society today. But what if these strategies and subtle cues that influence all of our decision-making processes were used to promote healthy items instead? Joining the show today to discuss the possibility of using behavioral economic based interventions to lead food consumers of all ages to healthier diets is Dr. David Just, whose recent paper, titled “Influencing the food choices of SNAP consumers: Lessons from economics, psychology and marketing” was just published in the Journal of Food Policy. Dr. Just is currently a professor and Director of Graduate Studies in the Charles H. Dyson School of Applied Economics and Management at Cornell University. He serves as co-director of the Cornell Center for Behavioral Economics in Child Nutrition Programs. David’s work uses the tools of psychology and economics to examine important ways in which misperception and emotion can drive economic decisions. Eating Matters is powered by Simplecast

How can schools use low-cost solutions to help children make healthier food choices? David Just is an expert on that topic. An economist by training, he is a professor at Cornell University and co-director, with Brian Wansink, of the Cornell Center for Behavioral Economics in Child Nutrition Programs (BEN Center). His research has included dozens of field and lab experiments that identify the subtle […] The post Using behavioral insights to design smarter school lunchrooms: An interview with David Just, Co-Director, Cornell Center for Behavioral Economics in Child Nutrition Programs – Episode #107 appeared first on Gov Innovator podcast.

A school cafeteria can be a highly charged environment. Crowds of students press into the line, eager to zip through so they can get to their friends and recess. They’re hungry. It’s very loud. And they’re only children. Can we really expect them to focus on healthy choices? Experts from the Cornell Center of Behavioral Economics say we can, with the help of simple, low or no-cost interventions at the point of sale. It’s just marketing, but it can work like magic. This program was brought to you by Whole Foods Market “When you look through a lunch room you really do have to examine it like a grocery store or a space where kids could purchase food.” [18:00] Kate Hoy on Inside School Food